Corza Medical Welcomes Jason Abair
Corza Medical is pleased to announce that Jason Abair has joined the team as Vice President, Legal & Chief Compliance Officer. With over twenty years of experience in legal roles across the medical device and pharmaceutical sectors, Jason is expected to contribute significant insights and skills to the organization.
An Established Legal Expert
Before his tenure at Corza Medical, Jason worked as Division General Counsel at Highridge Medical, LLC, which emerged from Zimmer Biomet and ZimVie. His past roles include serving as Associate General Counsel at Terumo Blood and Cell Technologies, Inc., and as Associate Vice President of Technology Transfer at The University of Texas Medical Branch. Additionally, Jason’s legal experience encompasses time spent as an attorney at the prestigious law firm Weil, Gotshal & Manges LLP.
Educational Qualifications
Jason earned a Bachelor of Science in Biology and Geology from Duke University, and he holds a Juris Doctorate from the University of Colorado School of Law. With this solid educational foundation and a wealth of practical experience, he is well-equipped to enhance Corza Medical’s legal strategies.
Leadership's Excitement
Tom Testa, CEO of Corza Medical, shared his excitement about Jason’s arrival: "We are thrilled to welcome Jason to our team. His legal expertise and background in the medical device sector will be invaluable as we work to advance our mission and foster innovation." This sentiment emphasizes the confidence in Jason's abilities to navigate legal frameworks while supporting the company’s goals.
His Role and Duties
In his new role, Jason will manage all legal affairs, including compliance initiatives, risk management strategies, and corporate governance. His leadership will be especially important as Corza Medical continues to grow and broaden its operations.
Focus on Governance and Compliance
During this strategic expansion for Corza Medical, Jason's role is crucial. By implementing strong corporate governance and compliance protocols, he will play a key role in protecting the company and its stakeholders.
A Dedication to Progress
Upon taking on his new position, Jason expressed, "I am excited to join Corza Medical and contribute to its ongoing success. I look forward to collaborating with the talented team here to deliver innovative solutions in medical products and technologies." His commitment to progress and creativity aligns seamlessly with Corza Medical's objectives.
About Corza Medical
Corza Medical is recognized as a top global manufacturer of cutting-edge surgical technologies. With a dedicated global workforce of over 3,000 employees, the company offers a range of surgical technologies designed to equip healthcare professionals with advanced solutions. Some of its leading brands include Quill barbed sutures, Sharpoint Plus surgical sutures, and Blink single-use ophthalmic instruments, amongst others.
Contact Us
If you’d like more information about Corza Medical and its leadership, please feel free to reach out via email at media@corza.com. For more details about the company itself, we invite you to visit their website.
Frequently Asked Questions
Who is Jason Abair?
Jason Abair is Corza Medical's new Vice President of Legal & Chief Compliance Officer, bringing a wealth of legal experience from the medical device industry.
What are Jason Abair's responsibilities at Corza Medical?
Jason oversees the legal affairs, compliance, and corporate governance at Corza Medical, especially as the company grows and expands its operations.
Where did Jason Abair work before joining Corza Medical?
Before joining Corza Medical, Jason held roles at Highridge Medical, Terumo Blood and Cell Technologies, and the University of Texas Medical Branch.
What is the focus of Corza Medical?
Corza Medical is dedicated to developing innovative surgical technologies that aid healthcare professionals and enhance patient care.
How can I learn more about Corza Medical?
You can find out more about Corza Medical by visiting their official website or by reaching out to their media relations team via email.
